In NSCLC, FBXW7 upregulation significantly increased cisplatin chemosensitivity and abrogated the mesenchymal phenotype of NSCLC cell lines (Yu et al., 2013). The gene discussed is FBXW7; the disease is non-small cell lung carcinoma.